Theravance, Inc. - Sales Analysis Snapshot

Business Description
This Report provides a comprehensive Sales & Margin summary analysis for Theravance, Inc. Tabular results include up to a ten-year history on Sales, EBITDA (Earnings before Interest, Taxes, Depreciation and Amortization), Income before Extraordinary Items and number of Employees. Additional ratios are included for sales growth, earnings and income as a percent of sales and Sales per Employee.

Theravance, Inc.. The Group's principal activity is that of a biopharmaceutical company with a pipeline of internally discovered product candidates. It focuses on the discovery, development and commercialization of small molecule medicines across a number of therapeutic areas including respiratory disease, bacterial infections and gastrointestinal motility dysfunction. Its programs include: telavancin for the treatment of serious Gram-positive bacterial infections with Astellas Pharma Inc. and Horizon program and the Bifunctional Muscarinic Antagonist-beta2 Agonist program with GlaxoSmithKline PLC.

Not the Report you are looking for? Click here for more browsing options.

view sample Single Report

view sample All Basic Reports

Layout and Content of a Typical Report